ElectroCore, which is commercializing a non-invasive nerve stimulation device for treating migraines, filed on Monday with the SEC to raise up to $75 million in an initial public offering.
The Basking Ridge, NJ-based company was founded in 2005 and booked $1 million in sales for the 12 months ended March 31, 2018. It plans to list on the Nasdaq under the symbol ECOR. ElectroCore filed confidentially on February 13, 2018. Piper Jaffray and Evercore ISI are the joint bookrunners on the deal. No pricing terms were disclosed.
